April 26, 2022 by John O'Brien
John O’Brien is president and chief executive officer of the National Pharmaceutical Council.
April 25, 2022, June 13, 2022, Opinion

The broad array of medicines available, from the newest innovation to the most tried-and-true generic, saves and improves the lives of patients everywhere, providing tremendous value. But the ecosystem in the United States that results in innovative medications being discovered and ultimately dispensed to patients at the pharmacy counter is hampered by an opaque pricing
April 26, 2022 by Eva Temkin and Christina Markus
Christina Markus and Eva Temkin are attorneys in King & Spalding’s Washington office, FDA
April 25, 2022, Opinion

More than 30 years ago, U.S. law mandated state licensure of prescription drug wholesale distributors, resulting in a patchwork of varying state requirements and practical burdens for multi-state businesses. In 2013, Congress passed the Drug Supply Chain Security Act (DSCSA), which was intended to strengthen the integrity of the pharmaceutical distribution supply chain and to
April 26, 2022 by David Ritter, David Schneidman and Cassie Ryding
Cassie Ryding is a manager at Alvarez & Marsal Consumer Retail Group, David Ritter is a managing director, David Schneidman is a director
April 25, 2022, Opinion

As the world emerges from several years of “pandemic living,” there are profound changes in customer preferences and purchasing behaviors on the horizon. These trends will have transformative, lasting impacts on the drug store beauty market. While some pandemic-induced trends, like buy online pick up in store (BOPIS) and ultra-fast delivery, appear to be here
April 26, 2022 by Deborah Weinswig
Deborah Weinswig is founder and chief executive officer of Coresight Research.
April 25, 2022, Opinion

Store closures are the order of the day among the major pharmacy chains, continuing a multiyear trend of consolidation of locations in the sector. This comes amid increasing digitalization and a push further into health care services by major chains, both necessitating significant investments by major retail names. However, pharmacy retailers must continue to invest
April 26, 2022 by Amar Singh
Amar Singh is senior director at Kantar.
April 25, 2022, Opinion

COVID-19 has had a profound impact on health and wellness shopping. The pandemic was a catalyst that blurred the boundary between health and wellness, with health subsuming wellness into its definition. As a result, brands and retailers are repositioning their products and services to focus more on health. Personal care products are now personal health
April 26, 2022 by Chain Drug Review
Sharon Leite, The Vitamin Shoppe
April 25, 2022, Leading Headlines

NEW YORK — When Sharon Leite joined The Vitamin Shoppe in 2018 as chief executive officer, the company had hit a speed bump after many years of steady growth and retail expansion. The industry had been changing rapidly, particularly around transformative digital and e-commerce technologies, but the 45-year-old company hadn’t quite transitioned with the times.
April 26, 2022 by Mindy Albuck
Mindy Albuck is client insights principal for Healthcare at IRI
April 25, 2022, Opinion

A CNN/Time/Harris study in 2002 found that an astounding 82% of Americans believed there was still a lot of stigma attached to mental illness. However, Americans are finally opening up more about mental health. In fact, a 2019 poll on behalf of the American Psychological Association found that 87% of American adults agreed that having
April 25, 2022 by Lari Harding
Lari Harding is vice president of client development at Inmar Intelligence.
April 25, 2022, Opinion

In the business of pharmacy, there is a cost to not having transparency. And there is a cost attached to transparency. The question is which of these is better for you and your customers. It’s an increasingly important question given the growth of health care. The consumer health care industry grew 12% in 2021 while
April 25, 2022 by Matt Kleinschmit
Matt Kleinschmit is founder and chief executive officer of Reach3 Insights
April 25, 2022, Opinion

Since their inception, pharmacies have strived to provide a quality health care experience for consumers. Over the past several decades, pharmacies have evolved from the small-town neighborhood store to major chains serving millions. In that time, they’ve implemented additional services for communities: In 2006, Walgreens was the first major chain to pioneer the in-store clinic,
April 25, 2022 by Todd Huseby, Rodey Wing and Kate Maheu
Kate Maheu is a principal in Kearney’s Health practice, Todd Huseby and Rodey Wing are partners in the Health practice at Kearney
April 25, 2022, Opinion

We are more than two years into COVID, and the health care industry still has an “edge of your seat” feel — even as the crisis wanes, there’s an uncertainty about what will happen next. This rings especially true for retail pharmacies, which experienced pandemic highs and lows. American consumers applauded as pharmacies elevated the
April 25, 2022 by Steven Robins
Steven Robins is managing partner/principal at the New England Consulting Group.
April 25, 2022, Opinion

While we don’t celebrate it, there is no question that the drug channel front of store has benefitted mightily from the pandemic. Increased traffic, new shoppers, pantry loading, digital downloads and ultimately millions of vaccinations have driven revenue and placed this channel squarely in the spotlight. The pandemic bent the trend curve, increasing store traffic
April 25, 2022 by Andrea Leigh
Andrea Leigh is founder and chief executive officer of Allume Group.
April 25, 2022, Opinion

Congratulations, you made it! 2021 was a year of transformation for both brands and retailers. Massive supply chain disruptions forced us to pivot when products ran out-of-stock. Retailers rushed to initiative delivery programs to accommodate shoppers’ needs. And as costs skyrocketed, further adjustments were made to ensure our endeavors were financially sustainable. As we think
April 25, 2022 by Leslie Lotano-Saba
Leslie Lotano-Saba is vice president of pharmacy solutions at global management consultancy AArete.
April 25, 2022, Opinion

The cyclone that hit the prescription drug industry may now seem in the distant past, but the events we’re about to discuss were set in full motion only two years ago. At the onset of the pandemic, there was widespread concern among patients who were worried about whether they’d be able to get their prescriptions
April 25, 2022 by Dan Leonard
Dan Leonard is president and chief executive officer of the Association for Accessible Medicines.
April 25, 2022, Opinion

U.S. patients may not fully understand the complex manufacturing and market dynamics that allow them to pay an average of just $6.61 for their generic prescription medicines at the pharmacy counter. That’s why tens of millions of Americans entrust their health to generics and biosimilars. In fact, fully 90% — nearly 4 billion in 2020